{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:44:34Z","timestamp":1792269874707,"version":"4.4.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100032516","name":"Medical School, University of Minnesota","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032516","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005187","name":"National and Kapodistrian University of Athens","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005187","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ard.2025.12.012","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T12:29:24Z","timestamp":1768998564000},"page":"858-872","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["CD40-CD40L inhibition attenuates platelet-neutrophil interaction and neutrophil extracellular trap release in primary antiphospholipid syndrome"],"prefix":"10.1016","volume":"85","author":[{"given":"Stavros","family":"Naoum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charilaos","family":"Spyropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andriani","family":"Angelopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harikleia","family":"Gakiopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michalis","family":"Katsimpoulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilis G.","family":"Gorgoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros P.","family":"Sfikakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Ritis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanna-Evdokia","family":"Galani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Kambas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2238-0975","authenticated-orcid":false,"given":"Maria G.","family":"Tektonidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ard.2025.12.012_bib0001","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/art.42624","article-title":"The 2023 ACR\/EULAR antiphospholipid syndrome classification criteria","volume":"75","author":"Barbhaiya","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ard.2025.12.012_bib0002","article-title":"Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management","volume":"380","author":"Knight","year":"2023","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.ard.2025.12.012_bib0003","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMra1112830","article-title":"The pathogenesis of the antiphospholipid syndrome","volume":"368","author":"Giannakopoulos","year":"2013","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ard.2025.12.012_bib0004","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.berh.2017.09.008","article-title":"Mechanisms of thrombosis in systemic lupus erythematosus and antiphospholipid syndrome","volume":"31","author":"De Groot","year":"2017","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"18","key":"10.1016\/j.ard.2025.12.012_bib0005","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.jacc.2017.02.058","article-title":"Antiphospholipid syndrome: role of vascular endothelial cells and implications for risk stratification and targeted therapeutics","volume":"69","author":"Corban","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ard.2025.12.012_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102813","article-title":"Cardiovascular disease risk in antiphospholipid syndrome: thrombo-inflammation and atherothrombosis","volume":"128","author":"Tektonidou","year":"2022","journal-title":"J Autoimmun"},{"issue":"4","key":"10.1016\/j.ard.2025.12.012_bib0007","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jtha.2022.12.002","article-title":"Targeting thromboinflammation in antiphospholipid syndrome","volume":"21","author":"Salet","year":"2023","journal-title":"J Thromb Haemost"},{"issue":"Suppl I","key":"10.1016\/j.ard.2025.12.012_bib0008","doi-asserted-by":"crossref","first-page":"SI4","DOI":"10.1093\/rheumatology\/kead603","article-title":"Antiphospholipid syndrome pathogenesis in 2023: an update of new mechanisms or just a reconsideration of the old ones?","volume":"63","author":"Raschi","year":"2024","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"10.1016\/j.ard.2025.12.012_bib0009","doi-asserted-by":"crossref","first-page":"e576","DOI":"10.1016\/S2665-9913(25)00094-3","article-title":"Towards precision medicine in antiphospholipid syndrome","volume":"7","author":"L\u00f3pez-Pedrera","year":"2025","journal-title":"Lancet Rheumatol"},{"issue":"22","key":"10.1016\/j.ard.2025.12.012_bib0010","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/eurheartj\/ehv007","article-title":"Expression of functional tissue factor by neutrophil extracellular traps in culprit artery of acute myocardial infarction","volume":"36","author":"Stakos","year":"2015","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.ard.2025.12.012_bib0011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045427","article-title":"Autophagy mediates the delivery of thrombogenic tissue factor to neutrophil extracellular traps in human sepsis","volume":"7","author":"Kambas","year":"2012","journal-title":"PLOS ONE"},{"issue":"10","key":"10.1016\/j.ard.2025.12.012_bib0012","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1136\/annrheumdis-2013-203430","article-title":"Tissue factor expression in neutrophil extracellular traps and neutrophil derived microparticles in antineutrophil cytoplasmic antibody associated vasculitis may promote thromboinflammation and the thrombophilic state associated with the disease","volume":"73","author":"Kambas","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.ard.2025.12.012_bib0013","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1136\/annrheumdis-2018-213181","article-title":"REDD1\/autophagy pathway promotes thromboinflammation and fibrosis in human systemic lupus erythematosus (SLE) through NETs decorated with tissue factor (TF) and interleukin-17A (IL-17A)","volume":"78","author":"Frangou","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.ard.2025.12.012_bib0014","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/cdd.2011.1","article-title":"Dying for a cause: NETosis, mechanisms behind an antimicrobial cell death modality","volume":"18","author":"Remijsen","year":"2011","journal-title":"Cell Death Differ"},{"issue":"5","key":"10.1016\/j.ard.2025.12.012_bib0015","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3390\/cells14050335","article-title":"Trapped in the NETs: multiple roles of platelets in the vascular complications associated with neutrophil extracellular traps","volume":"14","author":"Sennett","year":"2025","journal-title":"Cells"},{"issue":"12","key":"10.1016\/j.ard.2025.12.012_bib0016","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1182\/blood.2023022097","article-title":"Low ectonucleotidase activity and increased neutrophil-platelet aggregates in patients with antiphospholipid syndrome","volume":"143","author":"NaveenKumar","year":"2024","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ard.2025.12.012_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/imm.13901","article-title":"The role of platelet\u2013neutrophil interactions in driving autoimmune diseases","volume":"175","author":"Liu","year":"2025","journal-title":"Immunology"},{"issue":"6667","key":"10.1016\/j.ard.2025.12.012_bib0018","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/35393","article-title":"CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells","volume":"391","author":"Henn","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.ard.2025.12.012_bib0019","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.825892","article-title":"Platelets as key factors in inflammation: focus on CD40L\/CD40","volume":"13","author":"Cognasse","year":"2022","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.ard.2025.12.012_bib0020","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1111\/j.1538-7836.2010.04044.x","article-title":"A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score","volume":"8","author":"Barbar","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ard.2025.12.012_bib0021","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.824112","article-title":"Neutrophil-platelet interactions as novel treatment targets in cardiovascular disease","volume":"8","author":"Kaiser","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"22","key":"10.1016\/j.ard.2025.12.012_bib0022","doi-asserted-by":"crossref","first-page":"8533","DOI":"10.3390\/ijms21228533","article-title":"CD40\/CD40L and related signaling pathways in cardiovascular health and disease-the pros and cons for cardioprotection","volume":"21","author":"Daub","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.ard.2025.12.012_bib0023","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"9","key":"10.1016\/j.ard.2025.12.012_bib0024","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ard.2025.12.012_bib0025","article-title":"Stenosis of the inferior vena cava: a murine model of deep vein thrombosis","volume":"130","author":"Payne","year":"2017","journal-title":"J Vis Exp"},{"issue":"9","key":"10.1016\/j.ard.2025.12.012_bib0026","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1111\/jth.15785","article-title":"Added value of antiphosphatidylserine\/prothrombin antibodies in the workup of thrombotic antiphospholipid syndrome: communication from the ISTH SSC Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibodies","volume":"20","author":"Vandevelde","year":"2022","journal-title":"J Thromb Haemost"},{"issue":"6","key":"10.1016\/j.ard.2025.12.012_bib0027","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1161\/01.CIR.94.6.1239","article-title":"Increased neutrophil-platelet adhesion in patients with unstable angina","volume":"94","author":"Ott","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.ard.2025.12.012_bib0028","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1475-2840-2-12","article-title":"Platelet-neutrophil conjugate formation is increased in diabetic women with cardiovascular disease","volume":"2","author":"Tuttle","year":"2003","journal-title":"Cardiovasc Diabetol"},{"issue":"12","key":"10.1016\/j.ard.2025.12.012_bib0029","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1016\/j.immuni.2022.10.001","article-title":"Neutrophil \"plucking\" on megakaryocytes drives platelet production and boosts cardiovascular disease","volume":"55","author":"Petzold","year":"2022","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.ard.2025.12.012_bib0030","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nm1565","article-title":"Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood","volume":"13","author":"Clark","year":"2007","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.ard.2025.12.012_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102668","article-title":"Phoenix from the flames: Rediscovering the role of the CD40-CD40L pathway in systemic lupus erythematosus and lupus nephritis","volume":"19","author":"Ramanujam","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.ard.2025.12.012_bib0032","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/art.1780400509","article-title":"Thrombosis in primary antiphospholipid syndrome: a pivotal role for monocyte tissue factor expression","volume":"40","author":"Cuadrado","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.ard.2025.12.012_bib0033","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.4049\/jimmunol.177.7.4794","article-title":"A novel C5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways","volume":"177","author":"Ritis","year":"2006","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.ard.2025.12.012_bib0034","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1002\/art.39247","article-title":"Release of neutrophil extracellular traps by neutrophils stimulated with antiphospholipid antibodies: a newly identified mechanism of thrombosis in the antiphospholipid syndrome","volume":"67","author":"Yalavarthi","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"10.1016\/j.ard.2025.12.012_bib0035","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1182\/blood-2009-01-199117","article-title":"Role of tissue factor in a mouse model of thrombotic microangiopathy induced by antiphospholipid antibodies","volume":"114","author":"Seshan","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ard.2025.12.012_bib0036","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.3389\/fimmu.2018.01181","article-title":"Antiphospholipid syndrome nephropathy: from pathogenesis to treatment","volume":"9","author":"Tektonidou","year":"2018","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.ard.2025.12.012_bib0037","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1093\/rheumatology\/keae397","article-title":"Kidney whole-transcriptome profiling in primary antiphospholipid syndrome reveals complement, interferons and NETs-related gene expression","volume":"63","author":"Tektonidou","year":"2024","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.ard.2025.12.012_bib0038","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1055\/s-0040-1708035","article-title":"Thrombo-inflammation in cardiovascular disease: an expert consensus document from the third Maastricht Consensus Conference on Thrombosis","volume":"120","author":"d'Alessandro","year":"2020","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1016\/j.ard.2025.12.012_bib0039","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00441-017-2727-4","article-title":"Platelet\u2013neutrophil interactions as drivers of inflammatory and thrombotic disease","volume":"371","author":"Lisman","year":"2018","journal-title":"Cell Tissue Res"},{"issue":"10","key":"10.1016\/j.ard.2025.12.012_bib0040","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1182\/blood-2012-06-437772","article-title":"Tissue factor-positive neutrophils bind to injured endothelial wall and initiate thrombus formation","volume":"120","author":"Darbousset","year":"2012","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.ard.2025.12.012_bib0041","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.smim.2016.10.005","article-title":"Platelets and infection","volume":"28","author":"Deppermann","year":"2016","journal-title":"Semin Immunol"},{"issue":"4","key":"10.1016\/j.ard.2025.12.012_bib0042","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3109\/09537104.2015.1010441","article-title":"Platelets in inflammation and infection","volume":"26","author":"Jenne","year":"2015","journal-title":"Platelets"},{"issue":"6","key":"10.1016\/j.ard.2025.12.012_bib0043","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3109\/09537104.2015.1064881","article-title":"The role of platelets in the recruitment of leukocytes during vascular disease","volume":"26","author":"Ed Rainger","year":"2015","journal-title":"Platelets"},{"issue":"8","key":"10.1016\/j.ard.2025.12.012_bib0044","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1055\/s-0039-1692983","article-title":"Platelet-neutrophil crosstalk in atherothrombosis","volume":"119","author":"Pircher","year":"2019","journal-title":"Thromb Haemost"},{"issue":"7","key":"10.1016\/j.ard.2025.12.012_bib0045","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1055\/s-0039-1685453","article-title":"Platelet activation by antiphospholipid antibodies depends on epitope specificity and is prevented by mTOR inhibitors","volume":"119","author":"Hollerbach","year":"2019","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1016\/j.ard.2025.12.012_bib0046","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1182\/blood-2009-03-206367","article-title":"{beta}2 Glycoprotein I ({beta}2GPI) binds platelet factor 4 (PF4): implications for the pathogenesis of antiphospholipid syndrome","volume":"115","author":"Sikara","year":"2010","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ard.2025.12.012_bib0047","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/cei.13248","article-title":"Tissue factor over-expression in platelets of patients with anti-phospholipid syndrome: induction role of anti-\u03b22-GPI antibodies","volume":"196","author":"Capozzi","year":"2019","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"10.1016\/j.ard.2025.12.012_bib0048","first-page":"219","article-title":"Mechanisms sensitive to different drugs mediate a pro-adhesive and pro-thrombotic platelet phenotype in anti-phospholipid syndrome","volume":"111","author":"Camera","year":"2026","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.ard.2025.12.012_bib0049","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/s41577-023-00834-4","article-title":"The role of platelets in immune-mediated inflammatory diseases","volume":"23","author":"Scherlinger","year":"2023","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"10.1016\/j.ard.2025.12.012_bib0050","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1136\/annrheumdis-2019-215213","article-title":"EULAR recommendations for the management of antiphospholipid syndrome in adults","volume":"78","author":"Tektonidou","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.ard.2025.12.012_bib0051","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064631","article-title":"Soluble CD40 ligand stimulates CD40-dependent activation of the \u03b22 integrin Mac-1 and protein kinase C zeda (PKC\u03b6) in neutrophils: implications for neutrophil-platelet interactions and neutrophil oxidative burst","volume":"8","author":"Jin","year":"2013","journal-title":"PLOS ONE"},{"issue":"12","key":"10.1016\/j.ard.2025.12.012_bib0052","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014472","article-title":"The CD40-autophagy pathway is needed for host protection despite IFN-\u0393-dependent immunity and CD40 induces autophagy via control of P21 levels","volume":"5","author":"Portillo","year":"2010","journal-title":"PLOS ONE"},{"issue":"6367","key":"10.1016\/j.ard.2025.12.012_bib0053","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1126\/science.aam8897","article-title":"Host DNases prevent vascular occlusion by neutrophil extracellular traps","volume":"358","author":"Jim\u00e9nez-Alc\u00e1zar","year":"2017","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.ard.2025.12.012_bib0054","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1084\/jem.20112322","article-title":"Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo","volume":"209","author":"von Br\u00fchl","year":"2012","journal-title":"J Exp Med"},{"issue":"9","key":"10.1016\/j.ard.2025.12.012_bib0058","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1161\/ATVBAHA.119.312463","article-title":"Neutrophil extracellular traps: villains and targets in arterial, venous, and cancer-associated thrombosis","volume":"39","author":"Th\u00e5lin","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.ard.2025.12.012_bib0055","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13075-015-0757-4","article-title":"CDP7657, an anti-CD40L antibody lacking an Fc domain, inhibits CD40L-dependent immune responses without thrombotic complications: an in vivo study","volume":"17","author":"Shock","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"10.1016\/j.ard.2025.12.012_bib0056","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.1093\/rheumatology\/keab381","article-title":"Phase 2, randomized, placebo-controlled trial of dapirolizumab pegol in patients with moderate-to-severe active systemic lupus erythematosus","volume":"60","author":"Furie","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"10.1016\/j.ard.2025.12.012_bib0057","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1136\/annrheumdis-2017-211388","article-title":"Repeated administration of dapirolizumab pegol in a randomised phase I study is well tolerated and accompanied by improvements in several composite measures of systemic lupus erythematosus disease activity and changes in whole blood transcriptomic profiles","volume":"76","author":"Chamberlain","year":"2017","journal-title":"Ann Rheum Dis"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496725046060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496725046060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:04:52Z","timestamp":1792267492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496725046060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":58,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0003496725046060"],"URL":"https:\/\/doi.org\/10.1016\/j.ard.2025.12.012","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD40-CD40L inhibition attenuates platelet-neutrophil interaction and neutrophil extracellular trap release in primary antiphospholipid syndrome","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ard.2025.12.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology (EULAR).","name":"copyright","label":"Copyright"}]}}